 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
 |
| |
 |
 |
 |
 |
| |
 |
| |
 |
Other reports:
Report on China Power
Grid Construction and
Renovation of Province
& Municipal Power Grid
Market
Reports on energy
services in China
Production, Application
And Market Forecast Of
P-aminophenol
Market Analysis of
Benzene
Acid Anhydride Market
Analysis
China Plastic Market
2003
China Dichloroani
Production and Market
Analysis
China Plastic Pipe
Material And Piece
Market Analysis
Five years' Demand
Analysis Of China's
Plastic Industry
China Octanol
Production And 2002
Market Analysis
China Plastic
Processing Agent
Market Analysis And
Forecast
China Thick Nitric Acid
Market Analysis in 2003
China Acetone
Production and
Demand Analysis in
2003
PVC Market Analysis
China Alkali Production
And Consumption in
2003
China PE Production
And Demand Situation
And Market Forecast
China Automobile
Plastic Application And
Market Forecast
Dimethyl Sulfoxide
Production And Market
Analysis
Glacial Acetic Acid
Market Analysis
Grid Construction and
Renovation of Province
& Municipal Power Grid
Market
Reports on energy
services in China
Production, Application
And Market Forecast Of
P-aminophenol
Market Analysis of
Benzene
Acid Anhydride Market
Analysis
China Plastic Market
2003
China Dichloroani
Production and Market
Analysis
China Plastic Pipe
Material And Piece
Market Analysis
Five years' Demand
Analysis Of China's
Plastic Industry
China Octanol
Production And 2002
Market Analysis
China Plastic
Processing Agent
Market Analysis And
Forecast
China Thick Nitric Acid
Market Analysis in 2003
China Acetone
Production and
Demand Analysis in
2003
PVC Market Analysis
China Alkali Production
And Consumption in
2003
China PE Production
And Demand Situation
And Market Forecast
China Automobile
Plastic Application And
Market Forecast
Dimethyl Sulfoxide
Production And Market
Analysis
Glacial Acetic Acid
Market Analysis
 | |  | |  | |  | |  | |  | |  | |  |
Research Report on Traditional Chinese Drug Industry of China
Contents:
1.Industry Production
1.1.Products
1.1.1. Definition
1.1.2. General Classification of Chinese patent drug
1.1.3. An Introduction of the Grouping Management of Drugs in China
1.2.Production
1.2.1. Output and Product Structure (on the basis of fourteen categories)
1.2.2. Output Value and Regional Distribution
1.2.3. Productive Capacity and Development Capacity
1.2.4. Supply of Raw Materials
1.2.5. Overall Situation
1.2.6. Major Production Bases
1.2.7. Problems in the Supply of Raw Materials
2.Enterprises
2.1.The Total Number of Enterprises
2.2.Enterprise Quantity
2.3.Ustry Economy
2.4.The System of Ownership
2.5.Regional Distribution of Enterprises
2.6.China's Top Fifty Enterprises in Sales Revenue
2.7.GMP Certification
3.Group Analysis of Enterprises
3.1.Group Analysis of Enterprises Divided on the Basis of Sales revenue
3.1.1. Introduction
3.1.2. Analysis
3.2.Group Analysis of Enterprises divided on the Basis of Ownership
3.2.1. Introduction
3.2.2. Analysis
3.2.3. The Ownership and Per Capita Profit
3.3.Listed Companies in Traditional Chinese Drug Industry
3.4.Conclusion of the Group Analysis
4.Import and Export
4.1.Export
4.1.1. Export Volume
4.1.2. The Export Destination Countries
4.1.3. The Change in the Export Volume of Chinese Patent Drug
4.1.4. The Composition of Traditional Chinese Drug export
4.1.5. The Problems in the Export of Traditional Chinese drug
4.1.6. The Factors Against the Export of Traditional Chinese Drugs
4.1.7. The Factors in Favor of the Export of Traditional Chinese Drug
4.2.Import
4.2.1. The Composition of Traditional Chinese Drug Import
4.2.2. The Countries That Export Traditional Chinese Drug to China in
2002
5.Management and Policy
5.1. An Introduction of the Organizing Structure and Function of major
Administrative Departments of TCM Management in China
5.2.The Policies, Laws and Regulations in the Field of Drug Production
5.2.1. On the Supervision and Management of Drug Quality
5.2.2. On The Management of Drug production
5.2.3. An Brief Introduction of the Social Medical Security System of China
5.2.4. An Introduction to the List of Drugs under the Medical Insurance
System
5.2.5. An Introduction of the Traditional Chinese Drug Protection System
5.2.6. The Tenth Five-year Plan Concerning Traditional Chinese Drug
6.Chinese Patent Drug Market
6.1.The Scale of Market
6.2.Market Shares
6.3.The Distribution Channel, Classification and Expected Growth of
Drugs
6.4.China's Top Ten Chinese Patent Drugs and the Manufacturing
Enterprises
6.5.Drugs Sold in Hospitals
6.6. The Change and Current Situation of the Composition of Inpatients,
and the Impact of the Composition on the Market of Traditional Chinese
drugs
6.7.The Practice of Hospitals Inviting Bids for the Sales of Drug
6.8.The Reform of Drug Circulation System and Drug Chain Operation
7.Main Trends in the Medical Industry
7.1.Drug Price Reduction
7.2.Resource Restructuring
7.3.The Modernization of Traditional Chinese Drug
8.Market Prediction
9.Conclusion and Advice
9.1.Conclusion
9.2.A Few Pieces of Advice
10.Introduction of Representative Enterprises
Appendix 1, some main indices of Tongrentang
Appendix 2, some main indices of Guangzhou Pharmaceutical Company,
Appendix 3, some main indices of Kunming Pharmaceutical Company
Table
Table 1 Fourteen categories as percentages of total output
Table 2 China' top fifty enterprises in sales revenue
Table 3 The economic returns of enterprises of various ownerships in
Chinese patent drug industryChinese drug industry listed on Shanghai
and Shenzhen Stock Market
Table 5 The return on each share of listed companies in Chinese patent
drug industry
Table 6 Growth analysis
Table 7 Analysis on the profit-making ability
Table 8 Analysis on operation efficiency
Table 9 Analysis on capital structure and debt paying ability
Table 10 An introduction of the organizing structure and function of the
administrative departments of TCM management of China
Table 11 The surface demand of traditional Chinese drug market
Table 12 Market shares of medicinal products and traditional Chinese
medicinal products
Table 13 The distribution, classification and expected growth of drugs
Table 14 China's top ten Chinese patent drugs and the manufacturing
enterprises
Table 15 The top ten diseases suffered by inpatients in city hospitals of
the Ministry of Public Health of China
Table 16 The top ten diseases suffered by inpatients in county hospitals
of the Ministry of Public Health of China
Figure
Figure 1 The output and growth rate of Chinese patent drug
Figure 2 Fourteen categories as percentages of total output
Figure 3 Fourteen categories as percentages of total output
Figure 4 The output value and growth rate
Figure 5 The output value of Chinese patent drug as percentage of that of
the medical industry
Figure 6 The regional distribution of the annual output value of Chinese
patent drug
Figure 7 The output and utility rate of productive capacity of fourteen
categories
Figure 8 Colleges and research institutions of traditional Chinese
medicine
Figure 9 The quantity of Chinese patent drug enterprises as the
percentage of pharmaceutical industry
Figure 10 The quantity and percentage of enterprises of various scales
Figure 11 The percentage of output value and quantity of enterprises of
various scales
Figure 12 Enterprises of various ownership as percentages of the total
Chinese patent drug enterprises
Figure 13 The quantity of enterprises of various ownership in Chinese
patent drug industry
Figure 14 Regional distribution of enterprises in Chinese patent drug
industry
Figure 15 The composition of enterprises to be analyzed
Figure 16 The quantity of enterprises in various groups
Figure 17 Total sales revenue of enterprises in each group
Figure 18 The sales distribution by group
Figure 19 The profit of each group
Figure 20 The profit rate of each group
Figure 21 The per capita profit of each group
Figure 22 The asset profit rate of each group
Figure 23 The quantity and proportion of earning enterprises and losing
enterprises in each group
Figure 24 Some other ratios
Figure 25 The per capita sales revenue of enterprises of various
ownership
Figure 26 The per capita profit of enterprises of various ownership
Figure 27 The composition of traditional Chinese drug export
Figure 28 Main destination countries of traditional Chinese drug export
and their percentages in the total export volume
Figure 29 The composition of traditional Chinese drug export
Figure 30 The composition of traditional Chinese drug import
Figure 31 The countries that export traditional Chinese drug to China and
their percentages
Figure 32 The sales rates of some medical products
Figure 33 The output and sales rate of Chinese patent drug
Contents:
1.Industry Production
1.1.Products
1.1.1. Definition
1.1.2. General Classification of Chinese patent drug
1.1.3. An Introduction of the Grouping Management of Drugs in China
1.2.Production
1.2.1. Output and Product Structure (on the basis of fourteen categories)
1.2.2. Output Value and Regional Distribution
1.2.3. Productive Capacity and Development Capacity
1.2.4. Supply of Raw Materials
1.2.5. Overall Situation
1.2.6. Major Production Bases
1.2.7. Problems in the Supply of Raw Materials
2.Enterprises
2.1.The Total Number of Enterprises
2.2.Enterprise Quantity
2.3.Ustry Economy
2.4.The System of Ownership
2.5.Regional Distribution of Enterprises
2.6.China's Top Fifty Enterprises in Sales Revenue
2.7.GMP Certification
3.Group Analysis of Enterprises
3.1.Group Analysis of Enterprises Divided on the Basis of Sales revenue
3.1.1. Introduction
3.1.2. Analysis
3.2.Group Analysis of Enterprises divided on the Basis of Ownership
3.2.1. Introduction
3.2.2. Analysis
3.2.3. The Ownership and Per Capita Profit
3.3.Listed Companies in Traditional Chinese Drug Industry
3.4.Conclusion of the Group Analysis
4.Import and Export
4.1.Export
4.1.1. Export Volume
4.1.2. The Export Destination Countries
4.1.3. The Change in the Export Volume of Chinese Patent Drug
4.1.4. The Composition of Traditional Chinese Drug export
4.1.5. The Problems in the Export of Traditional Chinese drug
4.1.6. The Factors Against the Export of Traditional Chinese Drugs
4.1.7. The Factors in Favor of the Export of Traditional Chinese Drug
4.2.Import
4.2.1. The Composition of Traditional Chinese Drug Import
4.2.2. The Countries That Export Traditional Chinese Drug to China in
2002
5.Management and Policy
5.1. An Introduction of the Organizing Structure and Function of major
Administrative Departments of TCM Management in China
5.2.The Policies, Laws and Regulations in the Field of Drug Production
5.2.1. On the Supervision and Management of Drug Quality
5.2.2. On The Management of Drug production
5.2.3. An Brief Introduction of the Social Medical Security System of China
5.2.4. An Introduction to the List of Drugs under the Medical Insurance
System
5.2.5. An Introduction of the Traditional Chinese Drug Protection System
5.2.6. The Tenth Five-year Plan Concerning Traditional Chinese Drug
6.Chinese Patent Drug Market
6.1.The Scale of Market
6.2.Market Shares
6.3.The Distribution Channel, Classification and Expected Growth of
Drugs
6.4.China's Top Ten Chinese Patent Drugs and the Manufacturing
Enterprises
6.5.Drugs Sold in Hospitals
6.6. The Change and Current Situation of the Composition of Inpatients,
and the Impact of the Composition on the Market of Traditional Chinese
drugs
6.7.The Practice of Hospitals Inviting Bids for the Sales of Drug
6.8.The Reform of Drug Circulation System and Drug Chain Operation
7.Main Trends in the Medical Industry
7.1.Drug Price Reduction
7.2.Resource Restructuring
7.3.The Modernization of Traditional Chinese Drug
8.Market Prediction
9.Conclusion and Advice
9.1.Conclusion
9.2.A Few Pieces of Advice
10.Introduction of Representative Enterprises
Appendix 1, some main indices of Tongrentang
Appendix 2, some main indices of Guangzhou Pharmaceutical Company,
Appendix 3, some main indices of Kunming Pharmaceutical Company
Table
Table 1 Fourteen categories as percentages of total output
Table 2 China' top fifty enterprises in sales revenue
Table 3 The economic returns of enterprises of various ownerships in
Chinese patent drug industryChinese drug industry listed on Shanghai
and Shenzhen Stock Market
Table 5 The return on each share of listed companies in Chinese patent
drug industry
Table 6 Growth analysis
Table 7 Analysis on the profit-making ability
Table 8 Analysis on operation efficiency
Table 9 Analysis on capital structure and debt paying ability
Table 10 An introduction of the organizing structure and function of the
administrative departments of TCM management of China
Table 11 The surface demand of traditional Chinese drug market
Table 12 Market shares of medicinal products and traditional Chinese
medicinal products
Table 13 The distribution, classification and expected growth of drugs
Table 14 China's top ten Chinese patent drugs and the manufacturing
enterprises
Table 15 The top ten diseases suffered by inpatients in city hospitals of
the Ministry of Public Health of China
Table 16 The top ten diseases suffered by inpatients in county hospitals
of the Ministry of Public Health of China
Figure
Figure 1 The output and growth rate of Chinese patent drug
Figure 2 Fourteen categories as percentages of total output
Figure 3 Fourteen categories as percentages of total output
Figure 4 The output value and growth rate
Figure 5 The output value of Chinese patent drug as percentage of that of
the medical industry
Figure 6 The regional distribution of the annual output value of Chinese
patent drug
Figure 7 The output and utility rate of productive capacity of fourteen
categories
Figure 8 Colleges and research institutions of traditional Chinese
medicine
Figure 9 The quantity of Chinese patent drug enterprises as the
percentage of pharmaceutical industry
Figure 10 The quantity and percentage of enterprises of various scales
Figure 11 The percentage of output value and quantity of enterprises of
various scales
Figure 12 Enterprises of various ownership as percentages of the total
Chinese patent drug enterprises
Figure 13 The quantity of enterprises of various ownership in Chinese
patent drug industry
Figure 14 Regional distribution of enterprises in Chinese patent drug
industry
Figure 15 The composition of enterprises to be analyzed
Figure 16 The quantity of enterprises in various groups
Figure 17 Total sales revenue of enterprises in each group
Figure 18 The sales distribution by group
Figure 19 The profit of each group
Figure 20 The profit rate of each group
Figure 21 The per capita profit of each group
Figure 22 The asset profit rate of each group
Figure 23 The quantity and proportion of earning enterprises and losing
enterprises in each group
Figure 24 Some other ratios
Figure 25 The per capita sales revenue of enterprises of various
ownership
Figure 26 The per capita profit of enterprises of various ownership
Figure 27 The composition of traditional Chinese drug export
Figure 28 Main destination countries of traditional Chinese drug export
and their percentages in the total export volume
Figure 29 The composition of traditional Chinese drug export
Figure 30 The composition of traditional Chinese drug import
Figure 31 The countries that export traditional Chinese drug to China and
their percentages
Figure 32 The sales rates of some medical products
Figure 33 The output and sales rate of Chinese patent drug